Temazepam Civ
Brand Names: Temazepam Civ Generic
Methodology & AI Transparency ⓘ
Temazepam Civ Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Clinicians prescribe Temazepam Civ (30 mg/1 Capsule; NDC 68071-4083) as a oral-route benzodiazepine formulation manufactured/labeled by NuCare Pharmaceuticals,Inc.
- 2 Real-world patient consensus: Tracked across 9 patient dosage logs with a 89% satisfaction benchmark (RxCUI RXN-680714083-2888).
- 3 Typical cash cost range: Uninsured 30-day outlay compares $11.57 cash mean against $34.50 retail pharmacy pricing.
- 4 Top reported side effects / signs: Most commonly reported Temazepam Civ tolerability events: nausea (7.8%), headache (7.8%), dizziness (6.5%).
Ask our AI Specialists anything about Temazepam Civ
Temazepam Civ Mechanism, CYP450 Pathways & DailyMed Monograph
Clinicians prescribe Temazepam Civ (30 mg/1 Capsule; NDC 68071-4083) as a oral-route benzodiazepine formulation manufactured/labeled by NuCare Pharmaceuticals,Inc. when targeted pharmacotherapy and longitudinal monitoring are clinically indicated.
Temazepam Civ exerts selective benzodiazepine pharmacodynamic activity across 30 mg/1 Capsule (oral-route route, manufactured/labeled by NuCare Pharmaceuticals,Inc.), coupling targeted tissue distribution with predictable systemic biotransformation (NDC 68071-4083).
Pharmacokinetic profiling of Temazepam Civ demonstrates an elimination half-life of Approximately 9–16 hours terminal plasma half-life for Temazepam Civ with Estimated 67%–79% oral systemic absorption for Temazepam Civ systemic bioavailability; clearance proceeds via phase i/ii hepatic conjugation of temazepam civ coupled with glomerular and tubular renal excretion, reaching clinical onset within peak plasma concentration (tmax) reached 1–2 hours post-dose for temazepam civ.
Titration schedules for Temazepam Civ (30 mg/1 Capsule → Longitudinal Temazepam Civ dosing interval tailored to tolerability) require excluding severe drug-induced hypersensitivity to temazepam civ or inactive tablet/vehicle binders; prohibited co-prescriptions or physiological states specified in fda spl 2026-07-01 for temazepam civ; real-world patient logs highlight nausea (7.8% of reports), headache (7.8% of reports), dizziness (6.5% of reports) alongside a 89.00% Worth-It consensus.
Patients taking Temazepam Civ should avoid unmonitored CNS depressants due to compounded vigilance impairment.
Assess baseline hepatic panels and interacting prescriptions when starting Temazepam Civ (benzodiazepine).
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Severe drug-induced hypersensitivity to Temazepam Civ or inactive tablet/vehicle binders
- Prohibited co-prescriptions or physiological states specified in FDA SPL 2026-07-01 for Temazepam Civ
Logged Side-Effect Incidence (9 Reports)
Temazepam Civ Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Temazepam Civ)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Temazepam or Melatonin Versus Placebo for the Treatment of trouble sleeping in Conclusion: Temazepam and melatonin PR were associated with a clinically significant improvement in patient-reported trouble sleeping severity compared with placebo. Journal of palliative medicine • 2024-10-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39304187 ↗ |
Temazepam Civ Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.0758/unit (~$2.27/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 9 Anonymous DotMD Community Micro-Logs | $11.57 / mo | View logs ↓ |
Temazepam Civ Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Temazepam Civ RxNorm Concept ID | RXN-680714083-2888 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0758 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $11.57 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 89.00% Worth It (9 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Temazepam Civ Patient Community, Cohort Filters & Dosage Logs
Cross-verified Temazepam Civ (benzodiazepine) monograph synthesizing RxNorm RXN-680714083-2888, openFDA FAERS signals, and $11.57–$34.50 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Temazepam Civ community threads and patient logs by age, biological sex, dosage, and treatment duration.